Hjem
Universitetet i Bergen
Karin Margrethe Hjelles bilde

Karin Margrethe Hjelle

Førsteamanuensis
Klinisk institutt 1
  • E-postKarin.Hjelle@uib.no
  • Besøksadresse
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2024). Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up. Scandinavian Journal of Urology. 1-9.
  • Vis forfatter(e) (2024). Outcomes with the Adjustable Transobturator Male System (ATOMS) for the Treatment of Male Stress Urinary Incontinence After Prostate Surgery and the Impact of Previous Radiotherapy. European Urology Open Science. 68-73.
  • Vis forfatter(e) (2024). A preoperative magnetic resonance imaging can aid in staging and treatment choice for upper tract urothelial carcinoma. BJUI Compass.
  • Vis forfatter(e) (2021). The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma. Cytokine. 1-10.
  • Vis forfatter(e) (2020). The biological context of c-reactive protein as a prognostic marker in renal cell carcinoma: Studies on the acute phase cytokine profile. Cancers. 1-18.
  • Vis forfatter(e) (2020). Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunology and Immunotherapy. 1-12.
  • Vis forfatter(e) (2019). Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. The Lancet Oncology. 1602-1614.
  • Vis forfatter(e) (2018). National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival. European Urology Oncology (EUO). 252-261.
  • Vis forfatter(e) (2017). Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scandinavian Journal of Urology. 38-44.
  • Vis forfatter(e) (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. BMC Urology. 1-11.
  • Vis forfatter(e) (2016). Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLOS ONE.
  • Vis forfatter(e) (2016). Postoperative 30-day mortality rates for kidney cancer are dependent on hospital surgical volume: results from a Norwegian population-based study. European Urology Focus. 300-307.
  • Vis forfatter(e) (2016). Nephron Sparing Surgery Associated with Better Survival Than Radical Nephrectomy in Patients Treated for Unforeseen Benign Renal Tumors. Urology. 117-123.
  • Vis forfatter(e) (2016). Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. Scandinavian Journal of Urology. 452-462.
  • Vis forfatter(e) (2016). A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World Journal of Urology. 1087-1099.
  • Vis forfatter(e) (2015). Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian Journal of Urology. 388-394.
  • Vis forfatter(e) (2015). Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
  • Vis forfatter(e) (2015). Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma. Scandinavian Journal of Urology. 205-210.
  • Vis forfatter(e) (2014). Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology and Nephrology. 52-64.
  • Vis forfatter(e) (2013). Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 462-471.
  • Vis forfatter(e) (2012). Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 348-357.
  • Vis forfatter(e) (2002). Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy: The Journal of Arthroscopy And Related. 730-734.
Vitenskapelig foredrag
  • Vis forfatter(e) (2013). Psykometrisk validering av et diagnosespesifikt livskvalitets- skjema (HRQoL,) ment brukt sammen med det generelle EORTC livskvalitests- skjemaet (QLQ) på nyrekreft-pasienter.
  • Vis forfatter(e) (2013). Psychometric validation of a disease-specific Health Related Quality of Life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in Renal Cell Carcinoma patients.
  • Vis forfatter(e) (2012). Radiologisk vs. patologisk størrelse av nyrecellecarcinomer i stadium I og II - betydning for stadiumspesifikk overlevelse.
  • Vis forfatter(e) (2012). Oppstart med behandling av postprostatektomi inkontinens (PPI) ved Haukeland universitetssjukehus.
  • Vis forfatter(e) (2012). Evaluering av oppfølgningsprogrammet for nyrekreft (RCC)ved Haukeland universitetssjukehus.
Doktorgradsavhandling
  • Vis forfatter(e) (2018). A population based study on Kidney Cancer in Norway (2008 - 2013).
Sammendrag/abstract
  • Vis forfatter(e) (2016). Perioperative 30-day mortality rates are dependent on hospital surgical volume – results from a Norwegian population based study on surgical treatment for renal cell carcinoma. European Urology. Supplement. e520.
  • Vis forfatter(e) (2016). Changes in surgical treatment of modalities for renal cell carcinoma ≤ 7 cm – a Norwegian population based study 2008-2013. European Urology. Supplement. e1089.
  • Vis forfatter(e) (2013). Serum VEGF in patients with renal tumours and low contrast enhancement on ct can be used to predict survival and recurrence. Scandinavian Journal of Urology and Nephrology. 32-33.
  • Vis forfatter(e) (2013). Health related quality of life (HRQoL), personality and choice of coping is associated in renal cell carcinoma patients. Scandinavian Journal of Urology and Nephrology. 33-34.
Poster
  • Vis forfatter(e) (2013). Health related quality of life (HRQoL) personality and choice of coping is associated in renal cell carcinoma patinets.
Errata
  • Vis forfatter(e) (2021). Corrigendum to “The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma” [Cytokine 144 (2021) 155586](S1043466621001691)(10.1016/j.cyto.2021.155586). Cytokine.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2022). Management of Bladder Pain Syndrome (BPS): A Practical Guide. Advances in Urology. 1-9.
  • Vis forfatter(e) (2021). Current Status of Intravesical Therapies for Bladder Pain Syndrome (BPS): A Narrative Review of Emerging Evidence. Urology. e48-e57.
  • Vis forfatter(e) (2014). Traumatiske skader i nyra – ei orientering for dei utan spesialistkompetanse. Kirurgen. 119-123.

Se fullstendig oversikt over publikasjoner i CRIStin.